(25.2%)59,262 (27.6%)High cholesterol, N (%)53,141 (13.4%)30,670 (17.0%)22,471 (10.5%)Prevalent stroke events, N (%), any stroke before age 754543 (1.1%)2679 (1.5%)1864 (0.9%)Prevalent stroke events, N (%), ischaemic stroke before age 751152 (0.3%)787 (0.4%)365 (0.2%)Incident stroke events, N (%), any stroke before age 752607 (0.7%)1531 (0.8%)1076 (0.5%)Incident stroke events, N (%), ischaemic stroke before age 751923 (0.5%)1207 (0.7%)716 (0.3%)On blood-pressure lowering medication, N (%)80,880 (20.5%)43,714 (24.2%)37,166 (17.3%)On lipid-lowering medication, N (%)66,739 (16.9%)40,164 (22.2%)26,575 (12.4%)Follow-up time, years [mean (sd)]6.3 (1.9)6.2 (2.1)6.4 (1.8)Shown are characteristics obtained at the first UK Biobank assessment
